Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Head & Neck 1Gynecologic 1

Conditions

Obesity 28Neoplasms 10Overweight 8Breast Neoplasms 7Dyspnea 6Sexual Dysfunction, Physiological 5Mucositis 5Endometrial Neoplasms 5Pediatric Obesity 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Polycystic Ovary Syndrome 3Motor Activity 3Diabetes Mellitus, Type 2 3Weight Loss 2Uterine Cervical Neoplasms 2Syndrome 2Stomatitis 2Pulmonary Disease, Chronic Obstructive 2Pain 2Obesity-Related Malignant Neoplasm 2Leukemia 2Insulin Resistance 2Infertility 2Fatigue 2Endometrial Hyperplasia 2Cough 2Constipation 2Colorectal Neoplasms 2Vomiting 1Ulcer 1

Interventions

Tirzepatide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hyperplasia × Other × 90 days × Clear all
NCT07078838 2026-06-04

Tirzepatide in Women With Obesity and Endometrial Intra-epithelial Neoplasia or Grade 1 Endometrial Cancer

UNC Lineberger Comprehensive Cancer Center

Phase 2 Not yet recruiting
40 enrolled
GynecologicOther

Endometrial Hyperplasia, Hyperplasia, Obesity, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡